{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:27:37Z","timestamp":1781328457616,"version":"3.54.1"},"reference-count":39,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T00:00:00Z","timestamp":1280966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Aims\u2003<\/jats:bold> Naltrexone is a competitive opioid antagonist that effectively blocks the action of heroin and other opioid agonists. Sustained\u2010release naltrexone formulations are now available that provide long\u2010acting opioid blockade. This study investigates the use of heroin and other opioids among opioid\u2010dependent patients receiving treatment with long\u2010acting naltrexone implants, their subjective experience of drug \u2018high\u2019 after opioid use, and factors associated with opioid use.<\/jats:p><jats:p><jats:bold>Methods\u2003<\/jats:bold> Participants (<jats:italic>n<\/jats:italic>\u2003=\u200360) were opioid\u2010dependent patients receiving treatment with naltrexone implants. Outcome data on substance use, drug \u2018high\u2019, depression and criminal activity were collected over a 6\u2010month period. Blood samples were taken to monitor naltrexone plasma levels, and hair samples to verify self\u2010reported opioid use.<\/jats:p><jats:p><jats:bold>Findings\u2003<\/jats:bold> More than half [<jats:italic>n<\/jats:italic>\u2003=\u200334 or 56%; 95% confidence interval (CI) 44\u201368%)] the patients challenged the blockade with illicit opioids during the 6\u2010month treatment period; 44% (<jats:italic>n<\/jats:italic>\u2003=\u200326; 95% CI 32\u201356%) were abstinent from opioids. Mean opioid use was reduced from 18 [standard deviation (SD)13] days during the month preceding treatment to 6 days (SD 11) after 6 months. Of the respondents questioned on opioid \u2018high\u2019 (<jats:italic>n<\/jats:italic>\u2003=\u200331), nine patients (30%; 95% CI 16\u201347%) reported partial drug \u2018high\u2019 following illicit opioid use, and three (12%; 95% CI 3\u201326%) reported full \u2018high\u2019. Opioid use was associated with use of non\u2010opioid drugs and criminal behaviour.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> Challenging naltrexone blockade with heroin on at least one occasion is common among sustained\u2010release naltrexone patients, but only a minority of patients use opioids regularly. Challenges represent a warning sign for poor outcomes and often occur in the context of polydrug use and social adjustment problems.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2010.03031.x","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T13:52:40Z","timestamp":1281102760000},"page":"1633-1639","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Challenges to antagonist blockade during sustained\u2010release naltrexone treatment"],"prefix":"10.1111","volume":"105","author":[{"given":"Nikolaj","family":"Kun\u00f8e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lobmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K\u00e5re","family":"Vederhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rg","family":"Hjerkinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gossop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solfrid","family":"Hegstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8istein","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Waal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,5]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.01750360022003"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.131.6.646"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1976203315"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0509-x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952997509005663"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(81)90049-1"},{"key":"e_1_2_7_8_2","first-page":"S25","article-title":"Naltrexone: a clinical perspective","volume":"45","author":"Greenstein R. A.","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_9_2","first-page":"2","article-title":"Efficacy of naltrexone hydrochloride for preventing relapse among opiate\u2010dependent patients after detoxification","volume":"11","author":"Guo S.","year":"2001","journal-title":"Hong Kong J Psychiatry"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.2.210"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.06.013"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.8.1285"},{"key":"e_1_2_7_13_2","first-page":"85","volume-title":"Narcotics","author":"Wikler A.","year":"1965"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1037\/a0013049"},{"key":"e_1_2_7_15_2","first-page":"123","volume-title":"NIDA Research Monograph 9: Narcotic Antagonists: Naltrexone","author":"Meyer R.","year":"1976"},{"key":"e_1_2_7_16_2","first-page":"126","volume-title":"NIDA Research Monograph 19: The International Challenge of Drug Abuse","author":"Mello N. K.","year":"1978"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230412331289464"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.01817.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02252.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2007.tb00840.x"},{"key":"e_1_2_7_21_2","first-page":"107","article-title":"Classically conditioned phenomena in human opiate addiction","volume":"37","author":"O'Brien C. P.","year":"1981","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.9656771.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80047-2"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01402.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.055319"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/13556210410001674103"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.06.007"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000092115"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.3109\/16066350802531273"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-S"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000259089"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1207\/s15327752jpa7002_11"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/bs.3830190102"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02122.x"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/32.5.364"},{"key":"e_1_2_7_37_2","first-page":"136","article-title":"When 100% really isn't 100%: Improving the accuracy of small\u2010sample estimates of completion rates","volume":"1","author":"Lewis J. R.","year":"2006","journal-title":"J Usability Stud"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230500286039"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490500528464"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.8.755"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2010.03031.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2010.03031.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:11:27Z","timestamp":1698779487000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2010.03031.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,5]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1111\/j.1360-0443.2010.03031.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03031.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,5]]},"assertion":[{"value":"2010-08-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}